As we have discussed in previous posts, studies have shown that the hormones contained in the birth control product NuvaRing® have been linked to various forms of severe side-effects including: heart attack, stroke, deep vein thrombosis (also known as DVT or blood clots), internal organ damage, myocardial infarction and pulmonary embolism.
Judge Rodney W. Sippel, United States District Judge, is presiding over the federal litigation centralized in the Eastern District of Missouri. Judge Sippel set a case management conference for January 16, 2014. The trial in Prather v. Organon, 4:08-cv-558-RWS, is currently set to take place on April 7, 2014.
If you, or someone you know, has experienced adverse effects as a result of using Nuvaring®, you can contact Stark & Stark and speak to one of the Mass Tort/Pharmaceutical Litigation attorneys, free of charge, who can help assess any claims that you might have against the manufacturer of Nuvaring®.